Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
977 results:
1. Pan-cancer Analysis of PTBP1 to Identify it as a Prognostic and Immunological Biomarker.
Zhao Y; Wang Y; Xia Q; He H; Mao Q; Dong H; Zhu L; Hu Z; Xia J; Weng Z; Liao W; Xin Z
Cancer Control; 2024; 31():10732748241302865. PubMed ID: 39612472
[TBL] [Abstract] [Full Text] [Related]
2. Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer.
Nunes L; Stenersen JM; Kryeziu K; Sjöblom T; Glimelius B; Lothe RA; Sveen A
Mol Cancer; 2024 Nov; 23(1):264. PubMed ID: 39587554
[TBL] [Abstract] [Full Text] [Related]
3. MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression.
Liu J; Wei X; Xie Y; Yan Y; Xue S; Wang X; Chen H; Pan Q; Yan S; Zheng X; Huang Q
Cell Death Dis; 2024 Nov; 15(11):825. PubMed ID: 39543140
[TBL] [Abstract] [Full Text] [Related]
4. Association between KRAS mutation and alcohol consumption in Brazilian patients with colorectal cancer.
Gomes-Fernandes B; Trindade LM; de Castro Bastos Rodrigues M; Cardoso JPD; Lima FT; Rogerio L; de Vasconcelos Generoso S; Carneiro JG; da Silva RG; de Souza RP; De Marco L; Bastos-Rodrigues L
Sci Rep; 2024 Nov; 14(1):26445. PubMed ID: 39488539
[TBL] [Abstract] [Full Text] [Related]
5.
Nakano Y; Masuda T; Sakamoto T; Tanaka N; Tobo T; Hashimoto M; Tatsumi T; Saito H; Takahashi J; Koike K; Abe T; Ando Y; Ozato Y; Hosoda K; Hirose K; Higuchi S; Ikehara T; Hisamatsu Y; Toshima T; Yonemura Y; Ogino T; Uemura M; Eguchi H; Doki Y; Mimori K
Int J Oncol; 2024 Dec; 65(6):. PubMed ID: 39450547
[TBL] [Abstract] [Full Text] [Related]
6. Curcumin-loaded emulsome nanoparticles induces apoptosis through p53 signaling pathway in pancreatic cancer cell line PANC-1.
Demirci Z; Islek Z; Siginc HI; Sahin F; Ucisik MH; Bolat ZB
Toxicol In Vitro; 2025 Jan; 102():105958. PubMed ID: 39442639
[TBL] [Abstract] [Full Text] [Related]
7. Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.
Wang Z; Han H; Zhang C; Wu C; Di J; Xing P; Qiao X; Weng K; Hao H; Yang X; Hou Y; Jiang B; Su X
J Exp Clin Cancer Res; 2024 Sep; 43(1):274. PubMed ID: 39350250
[TBL] [Abstract] [Full Text] [Related]
8. SLC25A19 drives colorectal cancer progression by regulating p53.
Jiang J; Li X; Wang J; Chen S; Chen L
Cancer Med; 2024 Sep; 13(18):e70253. PubMed ID: 39344563
[TBL] [Abstract] [Full Text] [Related]
9. USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28.
Xu H; Wang T; Nie H; Sun Q; Jin C; Yang S; Chen Z; Wang X; Tang J; Feng Y; Sun Y
Oncogene; 2024 Nov; 43(47):3442-3455. PubMed ID: 39343961
[TBL] [Abstract] [Full Text] [Related]
10. A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against colorectal cancer.
Al-Nasser S; Abdulla MH; Alhassan N; Vaali-Mohammed MA; Al-Omar S; Hamdi N; Elnakady Y; Matou-Nasri S; Mansour L
Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336420
[No Abstract] [Full Text] [Related]
11. Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype.
Hrudka J; Kalinová M; Fišerová H; Jelínková K; Nikov A; Waldauf P; Matěj R
Sci Rep; 2024 Sep; 14(1):22241. PubMed ID: 39333321
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis.
Xin Z; Hu C; Zhang C; Liu M; Li J; Sun X; Hu Y; Liu X; Wang K
Redox Biol; 2024 Nov; 77():103362. PubMed ID: 39307047
[TBL] [Abstract] [Full Text] [Related]
13. Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.
Kasai S; Kagawa H; Hatakeyama K; Shiomi A; Manabe S; Yamaoka Y; Tanaka Y; Igaki T; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Kinugasa Y; Yamaguchi K
Int J Clin Oncol; 2024 Dec; 29(12):1887-1895. PubMed ID: 39287842
[TBL] [Abstract] [Full Text] [Related]
14. NLRC4, inflammation and colorectal cancer (Review).
Tong G; Shen Y; Li H; Qian H; Tan Z
Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239759
[TBL] [Abstract] [Full Text] [Related]
15. Cytotoxic Activity of
Gallegos-Saucedo R; Barrios-García T; Valdez-Morales EE; Cabañas-García E; Barajas-Espinosa A; Gómez-Aguirre YA; Guerrero-Alba R
Molecules; 2024 Aug; 29(16):. PubMed ID: 39202999
[TBL] [Abstract] [Full Text] [Related]
16. A CLRN3-Based CD8
Gong Z; Huang X; Cao Q; Wu Y; Zhang Q
Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281
[TBL] [Abstract] [Full Text] [Related]
17. PIK3CA Mutated colorectal cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes.
Voutsadakis IA
Cancer Genomics Proteomics; 2024; 21(5):533-548. PubMed ID: 39191495
[TBL] [Abstract] [Full Text] [Related]
18. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.
Foersch S; Schmitt M; Litmeyer AS; Tschurtschenthaler M; Gress T; Bartsch DK; Pfarr N; Steiger K; Denkert C; Jesinghaus M
J Pathol Clin Res; 2024 Sep; 10(5):e12394. PubMed ID: 39177576
[TBL] [Abstract] [Full Text] [Related]
19. miR-29a expression negatively correlates with Bcl-2 levels in colorectal cancer and is correlated with better prognosis.
Raonić J; Ždralević M; Vučković L; Šunjević M; Todorović V; Vukmirović F; Marzano F; Tullo A; Giannattasio S; Radunović M
Pathol Res Pract; 2024 Oct; 262():155491. PubMed ID: 39126835
[TBL] [Abstract] [Full Text] [Related]
20. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer.
Cao L; Ba Y; Chen F; Zhang S; Zhang H
Aging (Albany NY); 2024 Aug; 16(15):11606-11625. PubMed ID: 39115879
[TBL] [Abstract] [Full Text] [Related]
[Next]
